Immunotherapy for cancer that has spread to lymph nodes: a real-world study
Part of Cancer clinical trials.
This study looks at how well immunotherapy works for people whose cancer has spread to lymph nodes, and what factors affect its success. It uses real-world data from patients to help improve future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed solid tumor cancer (such as lung, stomach, colon, breast, or skin cancer).
- Your cancer has spread to lymph nodes, confirmed by imaging or biopsy.
- You have received at least one round of immunotherapy.
- You must be 18 years or older.
- Your medical records need to include details about your treatment and any beta-blocker use.
- You cannot have other active cancers or have had certain previous immunotherapies like vaccines or cell therapies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using T cells taken from your lymph nodes to fight advanced solid tumors that have not responded to standard therapies. The goal is to see if this approach can help shrink tumors or slow their growth.
This trial tests a new immune cell treatment made from your own lymph nodes for advanced solid tumors that haven't responded to standard therapies or have no good treatment options. It aims to see if this personalized cell therapy is safe and can help shrink tumors.
This trial tests if a specific type of lymph node surgery, combined with a short course of immunotherapy (medicines that help your immune system fight cancer), works better for melanoma that has spread to nearby lymph nodes. It's for people whose melanoma can be removed and who are healthy enough for treatment.
This study looks at how well immunotherapy (a type of cancer treatment that helps your immune system attack cancer cells) works for people with various types of cancer. You may join if you are already planning to receive this treatment, and the study will track your outcomes to help improve future care.
This trial tests a new cell therapy that uses your own immune cells (TILs) to fight lung cancer. If you have advanced non-small cell lung cancer and standard treatments haven't worked, this treatment might help your immune system attack the cancer more effectively.
This study looks at how well immunotherapy given before surgery works for non-small cell lung cancer. It aims to help doctors understand real-world outcomes for patients who receive this treatment.
Hear when a new Malignant Solid Tumors With Lymph Node Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.